Literature DB >> 8018763

The phenotype of L-CFU and its correlation with the immunological characteristics of the blast cell population in AML.

M C del Cañizo1, J Almeida, J F San Miguel, A Orfao, M Gonzalez, A Lopez Borrasca.   

Abstract

The membrane phenotype of AML clonogenic cells (L-CFU) was analyzed in 19 AML patients using an in vitro culture technique after a complement-mediated lysis assay employing a panel of six monoclonal antibodies (McAb) -HLA-DR, FMC56 (CD9), FMC27 (CD9), CD14, CD15, CD41a-. Our results show that L-CFU has a heterogeneous but immature phenotype lacking on the expression of differentiation antigens (CD14, CD15, CD41a). In addition, we observed that the L-CFU phenotype is different from that of the whole blast cell population. Interestingly, L-CFU showed a higher expression of HLA-DR antigens with respect to their progeny. Upon analyzing whether the L-CFU phenotype was related to both the morphological and immunological features of AML blast cells, it was observed that, while there is no correlation with the FAB classification, there was a partial relationship between the immunological phenotype of AML blast cells and that of L-CFU. Accordingly, the more immature AML cases showed a more differentiated L-CFU phenotype (HLA-DR+, CD9+, FMC27+) when compared with cases with a more mature blast cell phenotype. These results suggest that those AML cases with a relatively immature myeloblastic phenotype may arise from a progenitor cell that has undergone partial differentiation and that is unable to acquire myeloid differentiation antigens, while those AML cases with mature blast cells might emerge from a very early L-CFU that has the capacity to undergo a greater degree of differentiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018763     DOI: 10.1007/bf01737422

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  26 in total

1.  Evaluation of a monoclonal IgM antibody for purging of bone marrow for autologous transplantation.

Authors:  H Zola; A Potter; S H Neoh; C A Juttner; D N Haylock; A M Rice; E J Favaloro; A Kabral; K F Bradstock
Journal:  Bone Marrow Transplant       Date:  1987-02       Impact factor: 5.483

2.  Distribution of Ia-like molecules on the surface of normal and leukemic human cells.

Authors:  S F Schlossman; L Chess; R E Humphreys; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

3.  Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia.

Authors:  M D Minden; R N Buick; E A McCulloch
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

4.  Monoclonal antibodies against antigens of the human platelet surface: preparation and properties.

Authors:  H Zola; P J McNamara; I G Beckman; D A Brooks; P J Macardle; J Bradley; K Goodall; J Skinner; R Collins; M C Berndt
Journal:  Pathology       Date:  1984-01       Impact factor: 5.306

Review 5.  The use of monoclonal antibodies for the identification and classification of acute myeloid leukemias.

Authors:  H G Drexler; J Minowada
Journal:  Leuk Res       Date:  1986       Impact factor: 3.156

6.  Heterogeneity of clonogenic cells in acute myeloblastic leukemia.

Authors:  K D Sabbath; E D Ball; P Larcom; R B Davis; J D Griffin
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

8.  Antigens on human monocytes identified by monoclonal antibodies.

Authors:  R F Todd; L M Nadler; S F Schlossman
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

9.  Acute nonlymphocytic leukemia: heterogeneity of stem cell origin.

Authors:  P J Fialkow; J W Singer; J W Adamson; K Vaidya; L W Dow; J Ochs; J W Moohr
Journal:  Blood       Date:  1981-06       Impact factor: 22.113

10.  Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in in vivo cells from normal and leukemic patients.

Authors:  W Vainchenker; J F Deschamps; J M Bastin; J Guichard; M Titeux; J Breton-Gorius; A J McMichael
Journal:  Blood       Date:  1982-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.